Columbus® Congress Washington DC

Saturday, September 21, 2002

19.00 – 21.00

Welcome Reception at Belgium Embassy's Ambassador's Residence.

Sunday, September 22, 2002

10.00 – 12.30

SAB private session

Opening session – Chair: Michael Hawes, Belovo-US Inc.

The Columbus® Concept. What is it all about?

13.00 – 13.55	Dr. F. De Meester, Belovo S.A., Bastogne, Belgium
14.00 – 14.30	Discussion, Q/A session and final direction for the 2-d meeting

Monday, September 23, 2002

Session 1 : Presentation and discussion of the results from completed and planned clinical studies on Columbus® Egg – Chair: AJ Spinnler Benadé & Laurence Harbige

08.30 – 08.55	I. Watrin, Hôpital Universitaire des Enfants Reine Fabiola (Prof. D. Brasseur) & Nutrisub (Prof. Y. Carpentier), Brussels, Belgium Results from the feeding study with Columbus® Egg in FH-children under statin treatment
09.00 – 09.25	Prof. C.P. Martinez, Universidad Autonoma de Madrid, Spain Results from the feeding study with Columbus® Egg on the blood lipid composition and cardiovascular risk factors in women in the (post)-menopausal phase
09.30 – 09.55	Prof. J.-M. Lecerf, Institut Pasteur Lille, France Protocol of the feeding study with Columbus® Egg on the blood leptin concentration within healthy subjects
10.00 – 10.25	Dr. A.J.S. Benadé, MRC, Tygerberg, South Africa Protocol of the feeding study with Columbus® Egg and fish oil on the blood lipid and fatty acid profiles of normal and hypercholesterolaemic human volunteers
11.00 – 11.25	Dr. L. Harbige, University of Greenwich, London, UK Protocol of the feeding study with Columbus® Egg in egg-sensitive children
11.30 – 11.55	Dr. R.O. van Heukelom, Stichting CarePoint, The Netherlands Protocol of the feeding study with Columbus® Egg in type-2 diabetics and presentation of the CarePoint® organisation
12.00 – 12.25	Dr. N. Shapira, Medical & Natural Nutrition, Tel Aviv, Israël Protocol of the feeding study with Columbus® Egg on post prandial effect on lipemia and endothelial function

Session 2 : Mini-symposium on Omega-3 fatty acids, Evolution and Human Health – Chair: Harumi Okuyama & Artemis P Simopoulos

14.00 – 14.25	Prof. M.A. Crawford, Institute of Brain Chemistry and Human Nutrition, London, UK Docosahexaenoic acid: the secret to the evolution of the human brain
14.30 – 14.55	Prof. A.J. Sinclair, RMIT University, Melbourne, VIC, Australia Long chain PUFA in diets of Australian aborigines
15.00 – 15.25	Prof. M.J. Castillo-Garzon, Universidad de Grenada, Spain Changing the Spanish-Mediterranean diet. Effect on plasma lipid profile
15.30 – 15.55	Prof. H. Okuyama, Nagoya City University, Japan Suppression of allergic hyper-reactivity by lowering the n-6/n-3 ratio of dietary fatty acids – basic and clinical studies
16.30 – 16.55	Prof. A. Djazayery, Teheran University of Medical Sciences, Iran Wild fatty acids in human nutrition
17.00 – 17.25	Prof. C. von Schaky, Klinikum der Universität München, Germany Omega-3 fatty acids and cardiovascular diseases
17.30 – 17.55	Dr. M. de Lorgeril, Université Joseph Fourier, La Tronche Cedex, France The main lessons drawn from the Omega Diet book in cardiology
18.00 – 18.25	Prof. A.P. Simopoulos, CGNH, Washington, U.S.A. The return of omega-3 fatty acids into the food supply: an overview

Session 3: Video of SAB/DEPAI members and their opinion and vision for the Columbus® Concept – Chair: Michael Hawes, Belovo-US, Inc.

Tuesday, September 24, 2002

Session 4: Mini-symposium on animal husbandry and feed ingredients in compliance with the Columbus® Concept – Chair: Peter Surai & Jeong S Sim

09.00 – 09.25	Dr. L. Coucke, Vanden Avenne N.V., Ooigem, Belgium Columbus® feed around the world: selection of ingredients and potential influence on future international strategy for crop selection
09.30 – 09.55	Dr. P. Weill, Valorex S.A., Combourtillé, France The Bleu-Blanc-Coeur Concept in France
10.00 – 10.25	Dr. R. Ayerza, Functional Products S.A., Salta, Argentina Chia seeds as a new source of omega-3 fatty acids
11.00 – 11.25	Prof. P. Surai, SAC, Auchincruive, Scotland Simultaneous enrichement of eggs with PUFAs and antioxidants: prospects and limitation
11.30 – 11.55	Prof. J.S. Sim, AFNS, Edmonton, Alberta, Canada Designer egg oil for functional food uses
12.00 – 12.25	Patricia Appapoulay, University of Mauritius The Mauritius market for Designer Egg

Session 5: Mini-symposium on market review and growth projections and perspectives for the Columbus® Concept (egg, milk meat)

14.00 – 14.15	Mr. G. Villetard, Villetard Egg, Alberta, Canada The Dr. Sim Designer Egg in Canada
14.20 – 14.35	Mr. Naveed, Kool Komestibles, Bengalore, Karnataka, India The Diet Egg in India
14.40 – 14.55	Mr. C. Remacle, Belovo S.A., Bastogne, Belgium Mr. J-P Goeseels, Belovo S.A., Bastogne, Belgium The Columbus® Concept in Belgium
15.00 – 15.15	Mr. P. Challands, Deans Food Ltd, Tring, Herts, U.K. Mr. J. Stannard, Belovo-UK, Pitney, Somerset, U.K. The Columbus® Concept in the United Kingdom
15.20 – 15.35	Mr. J. Wijnia, Belovo NL, Rotstergaast, Holland The Columbus® Egg in the Netherlands
16.30 – 16.45	Mr. T. Tanaka, Nosan Corporation, Yokohama, Japan Mr. M. Ohi, Belovo-JP, Tokyo, Japan The Balance-21® Egg in Japan
16.50 – 17.05	Mr. J.M. Longtin, Belovo-FR, Lyon, France The Columbus® Egg in France
17.10 – 17.25	Mr. P. Lembke, Belovo-SP, Reus, Spain The Columbus® Egg in Spain
17.30 – 17.45	Mr. G. Muirhead, Chemiplas, Sydney, NSW,Australia The Columbus® Egg in Australia
17.50 – 18.05	Mr. M. Hawes, Belovo-US, Pinehurst, NC, U.S.A. The Columbus® Egg in the United States

Session 6: Video of SAB/DEPAI members and their opinion and vision for the Columbus® Concept – Chair: Michael Hawes, Belovo-US Inc.

Wednesday, September 25, 2002

Session 7: workshops – Chair: Fabien De Meester & Jean-Pierre Goeseels

09.00 – 09.35	DEPAI members: Merging Designer Egg with Columbus® Egg?
09.35 – 10.00	Dr. R. Katz, O3RI, Bethesda, MD, U.S.A. The concept of Columbus® egg trial in children with neurodevelopmental speech disorders.
10.00 – 11.00	Belovo Agents: Building the Belovo Group.